Weighing the GLP-1 Market
Goldman Sachs Exchanges
The Role of GLP-1 Medications in Obesity Treatment
Exploring how GLP-1 medications target brain pathways to regulate food intake and hunger, the chapter discusses historical and recent FDA-approved anti-obesity drugs. It delves into the variability of effectiveness in patients, responders versus non-responders, and considerations for treatment strategies and patient characteristics.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
